Clinical Trial

Combined Application of EEN in the Induction of Remission in PUC

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease had been well documented. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week12 will be compared between the two groups (combine with EEN group VS non-combine group).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-08-05; most recent amendment 2024-07-01.
Trial Details
NCT Number NCT04999241
Lead Sponsor Children's Hospital of Fudan University
Conditions Exclusive Enteral Nutrition, Ulcerative Colitis, Children
Enrollment 40 participants
Start Date 2025-03-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-03